Learn More
Medchemexpress LLC C34H31F2N3O3 | 2241651-99-8 | 99.8% | C34H31F2N3O3 | 10MG

Supplier: Medchemexpress LLC HY14516910MG
A small-molecule research compound that inhibits the CRMP2-Ubc9 interaction and NaV1.7 channels, with demonstrated oral activity in preclinical models of neuropathic pain. Supplied for research use only and not intended for human or clinical use.
- Inhibits CRMP2-Ubc9 interaction and NaV1.7 activity.
- Demonstrated oral efficacy in animal neuropathic pain models.
- High purity (≈99.8%).
- Powder stable at -20°C for up to 3 years.
- Solvent stability: -80°C for 6 months, -20°C for 1 month.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.